Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials.

Morgan R L LichtensteinLaura A LevitCaroline SchenkelKelsey KirkwoodLola A Fashoyin-AjeSuanna S BruinoogeMichael J KelleyJosh A MailmanAllison MagnusonDaniel P MirdaDivya NatesanDawn L Hershman

Published in: The oncologist (2023)

COVID-19 spurred the rise of TM/RPM in cancer treatment trials, and some TM/RPM use continues in this context. Among oncology researchers, higher levels of comfort compared with real-world experience with TM/RPM reveal opportunities for expanding TM/RPM policies and guidelines in oncology research.

Keyphrases

palliative care
coronavirus disease
sars cov
public health
genome wide
clinical practice
dna methylation